Developer docs
API playgroundTry for free, no card

Search company profiles

Sequentia Biotech

Full company profile

uuid0002cij

Namestring
Sequentia Biotech
Legal namestring
Sequentia Biotech S.L.
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Sequentia Biotech S.L. is a Barcelona-based bioinformatics company founded in 2013 that builds proprietary software platforms and provides consulting services to translate multiomics data — genomics, transcriptomics, metagenomics, epigenomics, proteomics, and metabolomics — into actionable biological and clinical insights. Its product portfolio spans AI-powered SaaS tools (AIR for RNA-Seq expression analysis, GAIA for metagenomics with benchmarked long-read performance), regulated clinical diagnostics (MICK Clinical, CE-IVD marked for gastrointestinal pathogen detection; MICK-MAGMA for tuberculosis genomics), research platforms (MICK for microbiome dysbiosis, GINO for human genomics, PROKY for outbreak surveillance, SABIO for genome safety), and workflow infrastructure (Sequentia Hub integration ecosystem and BatchX no-code job management). The company holds ISO 13485:2016, CE-IVD, GDPR, and HIPAA certifications, supporting both research-use and clinical diagnostic deployments, and has completed 900+ bioinformatics projects with 80+ peer-reviewed publications.

The company runs a hybrid go-to-market: product-led growth for AIR and GAIA via free trial and subscription (Stripe/PayPal/Braintree), and direct enterprise field sales for pharma, biotech, clinical labs, agricultural firms, and academic customers. Revenue streams include SaaS subscriptions, bioinformatics consulting, custom software development, sequencing services (including Oxford Nanopore long-read integration), training programs, and one-time CE-IVD product licenses. Customers span six primary verticals — Academic & Public Research Institutions, Pharma & Biotech, Clinical Diagnostic Labs, Agriculture & Agritech, Food & Nutrition Industry, and NGS Industry Partners — across 65+ countries, though no enterprise customer names are publicly disclosed. Notable technical collaborations include a Smart Bridge orchestration layer for Oxford Nanopore long-read sequencing in a European clinical diagnostics laboratory and AWS-hosted cloud delivery for SaaS and BatchX platforms.

Sequentia secured a €10 million Series A in October 2024 led by Seventure Partners (€7M) with co-investment from the European Innovation Council Fund (€3M), following earlier funding of approximately €2.5M from the EIC (October 2021) and a smaller EISMEA grant in 2017. The Series A is earmarked for commercialization and expansion of the MICK microbiome platform across biomedicine, precision medicine, agriculture, and food industries. Leadership: Walter Sanseverino serves as CEO and co-founder.

Short descriptiontext

Barcelona-based bioinformatics company (founded 2013) that builds proprietary multiomics software platforms (MICK, GAIA, AIR, GINO) and provides consulting, sequencing, and CE-IVD clinical diagnostic services to pharma, biotech, clinical labs, agriculture, and academic customers across 65+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBarcelona, Spain
HQ citystring
Barcelona
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
bioinformatics software, multi-omics analysis, genomic data analytics, metagenomics software, clinical diagnostic bioinformatics
Industry4 codes
PRIMARYHLAAAFAI
Microbiome Analytics, Sequencing & Bioinformatics Platforms
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGANAE
Transcriptomics & Gene Expression Profiling Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGAEAD
Genomics & Molecular Diagnostics (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
NAICS code4 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Software Publishers5132
  • Custom Computer Programming Services541511
  • Other Scientific and Technical Consulting Services54169
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Prepackaged Software7372
Product category
Bioinformatics Software
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model6 records
1SaaS Software Subscriptions (AIR, GAIA)
TypeSubscription Recurring
Description

Cloud-based software-as-a-service products for RNA-Seq analysis (AIR) and metagenomics (GAIA). Available via subscription with free trial access. Users register and subscribe through the website, with payment processed via Stripe, PayPal, and Braintree.

sequentiabiotech.com
2Bioinformatics Consulting Services
TypeProfessional Services
Description

End-to-end bioinformatics consulting supporting multiomics projects across experimental design, data analysis, and interpretation. Offered as a professional service to academic and industry clients.

sequentiabiotech.com
3Custom Software Development
TypeProfessional Services
Description

Development of bespoke bioinformatics pipelines, data visualization dashboards, and tailored analysis platforms for specific client research needs, delivered as project-based professional services.

sequentiabiotech.com
4Sequencing Services
TypeProfessional Services
Description

High-quality next-generation sequencing (NGS) data generation, including long-read Oxford Nanopore sequencing, seamlessly integrated with downstream bioinformatics analysis for end-to-end sample-to-insight services.

sequentiabiotech.com
5Training Services
TypeProfessional Services
Description

Hands-on bioinformatics training workshops and customized courses for teams, covering omics data analysis and interpretation. Offered as instructor-led or blended learning formats.

sequentiabiotech.com
6Licensed Diagnostic Products (CE-IVD)
TypeOne Time License
Description

CE-IVD certified clinical diagnostic products (MICK Clinical) licensed for use in clinical diagnostic laboratories in Europe. Represents a product license revenue stream beyond pure software SaaS.

sequentiabiotech.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Pricing details2 tiers
1SaaS subscription with free trial (AIR, GAIA)
ModelFreemiumBilling cadenceMonthly
Notes

AIR (AI-powered RNA-Seq) and GAIA (metagenomics) are offered as SaaS products with free trial access. Specific subscription tiers and pricing are not publicly disclosed; users subscribe through the website and payment is processed via Stripe, PayPal, and Braintree.

sequentiabiotech.com
2Enterprise services (consulting, custom software, sequencing)
ModelOtherBilling cadenceMulti-year contract
Notes

Consulting, custom software development, sequencing services, and training are sold as professional services with quote-based pricing. No public price list is available; engagements are initiated through contact/demo request forms.

sequentiabiotech.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 8 records shown
1MICK
Description

Microbiome Dysbiosis Insights platform for microbiome analysis

sequentiabiotech.com
+7 more records
Core offering1 text field

Sequentia Biotech develops and sells proprietary bioinformatics software platforms (MICK, GAIA, AIR, GINO, PROKY, SABIO, BatchX, Sequentia Hub) that transform multiomics sequencing data into actionable biological and clinical insights. The company delivers these platforms alongside end-to-end bioinformatics consulting, custom software development, sequencing services, and training programs to pharma, biotech, clinical diagnostic labs, academic institutions, agriculture, and food industry clients across 65+ countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Over 900 bioinformatics projects completed
+3 more records
Product overview1 text field

Sequentia Biotech offers a platform-plus-modules architecture centered on bioinformatics solutions for omics data analysis. The core commercial SaaS products are AIR (AI-powered RNA-Seq expression analysis) and GAIA (universal metagenomics software), sold as subscription services. The MICK product line provides microbiome analysis capabilities, including MICK Clinical (CE-IVD marked clinical diagnostic for GI pathogen detection), MICK-MAGMA (TB genomics), and the base MICK platform for microbiome dysbiosis insights. Supporting products include GINO (human genomics), PROKY (outbreak detection), and SABIO (genome safety). The ecosystem is unified through Sequentia Hub (integration platform) and BatchX (no-code job management). The company also provides associated services including bioinformatics consulting, custom software development, sequencing services, and training programs.

Product and service15 records
1MICK (Microbiome Dysbiosis Insights)
CategoryMicrobiome Analysis Software
Description

Proprietary microbiome analysis platform providing species-level profiling and dysbiosis assessments for human health diagnostics and research applications, available to pharma, biotech, clinical labs, academic, and food industry clients.

2MICK Clinical (CE-IVD)
CategoryClinical Diagnostic Software
Description

CE-IVD certified clinical diagnostic product for automated gastrointestinal pathogen detection and identification from patient samples, licensed for clinical use in European diagnostic laboratories.

3MICK-MAGMA (TB Genomics & Treatment)
CategoryGenomic Diagnostics Software
Description

Genomic and resistance profiling solution for tuberculosis providing treatment insights to support clinical decision-making for TB patients.

4GAIA (Metagenomics Insights)
CategoryMetagenomics Software (SaaS)
Description

Universal metagenomic analysis software for taxonomic classification of microorganisms from diverse sequencing datasets, supporting both short-read and long-read technologies. Offered as a SaaS product with free trial access.

5GAIA Clinical (RUO)
CategoryClinical Metagenomics Software
Description

Clinical metagenomics solution (Research Use Only) enabling comprehensive microbial profiling from clinical samples for research applications in clinical laboratories.

6GINO (Human Genomics)
CategoryHuman Genomics Software
Description

Proprietary human genomics platform for analyzing human genetic variation and gene expression patterns to support genomic research and clinical interpretation.

7AIR (RNA-Seq Expression Analysis)
CategoryRNA-Seq Analysis Software (SaaS)
Description

AI-powered RNA-Seq expression analysis software for gene expression profiling, differential expression analysis, and biomarker discovery, offered as a SaaS subscription with free trial access.

8PROKY (Outbreak Detection & Analysis)
CategoryPublic Health Surveillance Software
Description

Outbreak detection and surveillance platform for epidemiology and public health applications, enabling identification and analysis of disease outbreak patterns.

9SABIO (Genome Safety Software)
CategoryGenome Safety Software
Description

Genome safety software for food and industrial applications, ensuring genomic analysis quality and biosafety compliance for production organisms.

10Sequentia Hub
CategoryBioinformatics Integration Platform
Description

Connected cloud-based ecosystem platform integrating all Sequentia bioinformatics solutions, enabling centralized data management, workflow automation, and cross-platform analysis.

11BatchX
CategoryNo-code Workflow Platform
Description

No-code cloud platform enabling users to manage and execute bioinformatics jobs without programming expertise, providing accessible workflow control for bioinformatics teams.

12Bioinformatics Consulting
CategoryProfessional Services
Description

End-to-end bioinformatics consulting supporting multiomics projects across experimental design, data analysis, and interpretation for academic and industry clients.

13Custom Software Development
CategoryProfessional Services
Description

Custom bioinformatics pipeline, data visualization dashboard, and analysis platform development tailored to specific research or operational requirements, delivered as project-based engagements.

14Sequencing Services
CategorySequencing Services
Description

High-quality next-generation sequencing (NGS) data generation including long-read Oxford Nanopore sequencing, seamlessly integrated with downstream bioinformatics analysis for end-to-end sample-to-insight workflows.

15Training
CategoryTraining Services
Description

Hands-on bioinformatics workshops and customized courses equipping teams with skills and knowledge to independently manage and interpret omics data, offered as instructor-led or blended learning formats.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeTechnology or Integration
Description

Sequentia Biotech partnered with a large European clinical diagnostics laboratory to implement its Smart Bridge orchestration layer for Oxford Nanopore (ONT) long-read sequencing. The specialized bridge converts raw ONT sequencing output into standardized, clinician-ready reports, creating an automated 'pore to PDF' ecosystem integrated with ONT's sequencing platform.

Strategic tierCoreTypeTechnology or Integration
Description

Sequentia Biotech's cloud-based platforms (BatchX, Sequentia Hub, and SaaS products AIR and GAIA) are hosted on cloud infrastructure, with AWS referenced as the hosting provider. The company leverages cloud computing for scalable bioinformatics analysis, data storage, and platform delivery.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global life sciences leader providing sample-prep and bioinformatics tools (CLC Genomics Workbench, GeneGlobe) for genomics and clinical diagnostics. Comparable to Sequentia in serving pharma/biotech and clinical labs with integrated bioinformatics, but at vastly larger scale and as part of a broader consumables portfolio.

TypeBroad incumbent
Description

Dominant sequencing platform vendor increasingly bundling bioinformatics (DRAGEN, BaseSpace). Comparable as an end-to-end provider for genomics customers, though Illumina's primary moat is sequencing hardware rather than software interpretation.

TypeDirect peer
Description

Clinical genomics AI platform serving hospitals and clinical labs with multiomics interpretation, including metagenomics and rare disease applications. Closely comparable to Sequentia in combining clinical-grade certification, AI-driven interpretation, and SaaS deployment for clinical diagnostics customers.

TypeDirect peer
Description

Cloud-based genomics informatics platform serving pharma/biotech and clinical customers with analysis pipelines and data management. Comparable to Sequentia Hub as a cloud bioinformatics ecosystem, though DNAnexus focuses more on infrastructure and large pharma deployments.

TypeDirect peer
Description

Cloud platform for biotech R&D including molecular biology and genomics workflows, serving pharma/biotech enterprise customers. Comparable to Sequentia as a SaaS bioinformatics platform for life science R&D, though Benchling's emphasis is broader R&D informatics rather than omics interpretation.

TypeDirect peer
Description

Bioinformatics software provider specializing in genomics and transcriptomics analysis (Partek Flow, Partek Genomics Suite). Comparable to Sequentia's AIR and GINO products for academic and pharma customers seeking user-friendly omics analysis.

TypeBroad incumbent
Description

Scientific R&D informatics platform serving pharma/biotech customers with data management and analysis workflows. Comparable to Sequentia in targeting pharma R&D with integrated data/analysis offerings, though Dotmatics spans broader chemistry and biology informatics.

TypeBroad incumbent
Description

Enterprise bioinformatics platform for pharma/biotech R&D with specialized omics and screening analysis modules. Comparable to Sequentia Hub as an enterprise-scale platform for multiomics interpretation in pharma R&D contexts.

TypeDirect peer
Description

Visualization and analysis software for omics data including genomics, transcriptomics, and proteomics, serving clinical and research customers. Comparable to Sequentia's AIR/GAIA as a specialized omics interpretation tool with CE-marked clinical variants.

TypeDirect peer
Description

Bioinformatics platform applying AI to microbiome and multiomics analysis for enterprise customers in consumer goods, food, and life sciences. Closely comparable to Sequentia's microbiome focus and cross-vertical positioning in food/agriculture/health.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sequentia Biotech

Bioinformatics Softwaresequentiabiotech.com

Barcelona-based bioinformatics company (founded 2013) that builds proprietary multiomics software platforms (MICK, GAIA, AIR, GINO) and provides consulting, sequencing, and CE-IVD clinical diagnostic services to pharma, biotech, clinical labs, agriculture, and academic customers across 65+ countries.

What Sequentia Biotech does

Sequentia Biotech S.L. is a Barcelona-based bioinformatics company founded in 2013 that builds proprietary software platforms and provides consulting services to translate multiomics data — genomics, transcriptomics, metagenomics, epigenomics, proteomics, and metabolomics — into actionable biological and clinical insights. Its product portfolio spans AI-powered SaaS tools (AIR for RNA-Seq expression analysis, GAIA for metagenomics with benchmarked long-read performance), regulated clinical diagnostics (MICK Clinical, CE-IVD marked for gastrointestinal pathogen detection; MICK-MAGMA for tuberculosis genomics), research platforms (MICK for microbiome dysbiosis, GINO for human genomics, PROKY for outbreak surveillance, SABIO for genome safety), and workflow infrastructure (Sequentia Hub integration ecosystem and BatchX no-code job management). The company holds ISO 13485:2016, CE-IVD, GDPR, and HIPAA certifications, supporting both research-use and clinical diagnostic deployments, and has completed 900+ bioinformatics projects with 80+ peer-reviewed publications.

The company runs a hybrid go-to-market: product-led growth for AIR and GAIA via free trial and subscription (Stripe/PayPal/Braintree), and direct enterprise field sales for pharma, biotech, clinical labs, agricultural firms, and academic customers. Revenue streams include SaaS subscriptions, bioinformatics consulting, custom software development, sequencing services (including Oxford Nanopore long-read integration), training programs, and one-time CE-IVD product licenses. Customers span six primary verticals — Academic & Public Research Institutions, Pharma & Biotech, Clinical Diagnostic Labs, Agriculture & Agritech, Food & Nutrition Industry, and NGS Industry Partners — across 65+ countries, though no enterprise customer names are publicly disclosed. Notable technical collaborations include a Smart Bridge orchestration layer for Oxford Nanopore long-read sequencing in a European clinical diagnostics laboratory and AWS-hosted cloud delivery for SaaS and BatchX platforms.

Sequentia secured a €10 million Series A in October 2024 led by Seventure Partners (€7M) with co-investment from the European Innovation Council Fund (€3M), following earlier funding of approximately €2.5M from the EIC (October 2021) and a smaller EISMEA grant in 2017. The Series A is earmarked for commercialization and expansion of the MICK microbiome platform across biomedicine, precision medicine, agriculture, and food industries. Leadership: Walter Sanseverino serves as CEO and co-founder.

Sequentia Biotech firmographics

Firmographics
Name
Sequentia Biotech
Legal name
Sequentia Biotech S.L.
Website
https://sequentiabiotech.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
11–50 employees
Short description
Barcelona-based bioinformatics company (founded 2013) that builds proprietary multiomics software platforms (MICK, GAIA, AIR, GINO) and provides consulting, sequencing, and CE-IVD clinical diagnostic services to pharma, biotech, clinical labs, agriculture, and academic customers across 65+ countries.
Ownership category
akta.pro rank

Sequentia Biotech industry classification

Industry
Product category
Bioinformatics Software
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Software Publishers (5132), Custom Computer Programming Services (541511), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAAAFAI
Microbiome Analytics, Sequencing & Bioinformatics Platforms
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGANAE
Transcriptomics & Gene Expression Profiling Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGAEAD
Genomics & Molecular Diagnostics (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

  • Bioinformatics software
  • Multi-omics analysis
  • Genomic data analytics
  • Metagenomics software
  • Clinical diagnostic bioinformatics

Where Sequentia Biotech is headquartered

Location

Headquarters

HQ city
Barcelona
HQ country
Spain
HQ region
Europe

Offices2 records

Markets served

Sequentia Biotech business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. SaaS Software Subscriptions (AIR, GAIA): Cloud-based software-as-a-service products for RNA-Seq analysis (AIR) and metagenomics (GAIA). Available via subscription with free trial access. Users register and subscribe through the website, with payment processed via Stripe, PayPal, and Braintree.
  2. Bioinformatics Consulting Services: End-to-end bioinformatics consulting supporting multiomics projects across experimental design, data analysis, and interpretation. Offered as a professional service to academic and industry clients.
  3. Custom Software Development: Development of bespoke bioinformatics pipelines, data visualization dashboards, and tailored analysis platforms for specific client research needs, delivered as project-based professional services.
  4. Sequencing Services: High-quality next-generation sequencing (NGS) data generation, including long-read Oxford Nanopore sequencing, seamlessly integrated with downstream bioinformatics analysis for end-to-end sample-to-insight services.
  5. Training Services: Hands-on bioinformatics training workshops and customized courses for teams, covering omics data analysis and interpretation. Offered as instructor-led or blended learning formats.
  6. Licensed Diagnostic Products (CE-IVD): CE-IVD certified clinical diagnostic products (MICK Clinical) licensed for use in clinical diagnostic laboratories in Europe. Represents a product license revenue stream beyond pure software SaaS.

Pricing tiers

ModelBillingPrice
FreemiumMonthlySaaS subscription with free trial (AIR, GAIA)
OtherMulti-year contractEnterprise services (consulting, custom software, sequencing)

Go-to-market motion2 records

Distribution channels3 records

Marketing channels9 records

Sequentia Biotech product offering

Product offering

Core offering

Sequentia Biotech develops and sells proprietary bioinformatics software platforms (MICK, GAIA, AIR, GINO, PROKY, SABIO, BatchX, Sequentia Hub) that transform multiomics sequencing data into actionable biological and clinical insights. The company delivers these platforms alongside end-to-end bioinformatics consulting, custom software development, sequencing services, and training programs to pharma, biotech, clinical diagnostic labs, academic institutions, agriculture, and food industry clients across 65+ countries.

Product overview

Sequentia Biotech offers a platform-plus-modules architecture centered on bioinformatics solutions for omics data analysis. The core commercial SaaS products are AIR (AI-powered RNA-Seq expression analysis) and GAIA (universal metagenomics software), sold as subscription services. The MICK product line provides microbiome analysis capabilities, including MICK Clinical (CE-IVD marked clinical diagnostic for GI pathogen detection), MICK-MAGMA (TB genomics), and the base MICK platform for microbiome dysbiosis insights. Supporting products include GINO (human genomics), PROKY (outbreak detection), and SABIO (genome safety). The ecosystem is unified through Sequentia Hub (integration platform) and BatchX (no-code job management). The company also provides associated services including bioinformatics consulting, custom software development, sequencing services, and training programs.

Differentiator

Problem solved

Functional benefit

Brands

  • MICK: Microbiome Dysbiosis Insights platform for microbiome analysis
  • GAIA
  • GINO
  • AIR
  • PROKY
  • SABIO
  • BatchX
  • Sequentia Hub

Products and services

  • MICK (Microbiome Dysbiosis Insights) Proprietary microbiome analysis platform providing species-level profiling and dysbiosis assessments for human health diagnostics and research applications, available to pharma, biotech, clinical labs, academic, and food industry clients.
  • MICK Clinical (CE-IVD) CE-IVD certified clinical diagnostic product for automated gastrointestinal pathogen detection and identification from patient samples, licensed for clinical use in European diagnostic laboratories.
  • MICK-MAGMA (TB Genomics & Treatment) Genomic and resistance profiling solution for tuberculosis providing treatment insights to support clinical decision-making for TB patients.
  • GAIA (Metagenomics Insights) Universal metagenomic analysis software for taxonomic classification of microorganisms from diverse sequencing datasets, supporting both short-read and long-read technologies. Offered as a SaaS product with free trial access.
  • GAIA Clinical (RUO) Clinical metagenomics solution (Research Use Only) enabling comprehensive microbial profiling from clinical samples for research applications in clinical laboratories.
  • GINO (Human Genomics) Proprietary human genomics platform for analyzing human genetic variation and gene expression patterns to support genomic research and clinical interpretation.
  • AIR (RNA-Seq Expression Analysis) AI-powered RNA-Seq expression analysis software for gene expression profiling, differential expression analysis, and biomarker discovery, offered as a SaaS subscription with free trial access.
  • PROKY (Outbreak Detection & Analysis) Outbreak detection and surveillance platform for epidemiology and public health applications, enabling identification and analysis of disease outbreak patterns.
  • SABIO (Genome Safety Software) Genome safety software for food and industrial applications, ensuring genomic analysis quality and biosafety compliance for production organisms.
  • Sequentia Hub Connected cloud-based ecosystem platform integrating all Sequentia bioinformatics solutions, enabling centralized data management, workflow automation, and cross-platform analysis.
  • BatchX No-code cloud platform enabling users to manage and execute bioinformatics jobs without programming expertise, providing accessible workflow control for bioinformatics teams.
  • Bioinformatics Consulting End-to-end bioinformatics consulting supporting multiomics projects across experimental design, data analysis, and interpretation for academic and industry clients.
  • Custom Software Development Custom bioinformatics pipeline, data visualization dashboard, and analysis platform development tailored to specific research or operational requirements, delivered as project-based engagements.
  • Sequencing Services High-quality next-generation sequencing (NGS) data generation including long-read Oxford Nanopore sequencing, seamlessly integrated with downstream bioinformatics analysis for end-to-end sample-to-insight workflows.
  • Training Hands-on bioinformatics workshops and customized courses equipping teams with skills and knowledge to independently manage and interpret omics data, offered as instructor-led or blended learning formats.

Quantifiable outcome

  • Over 900 bioinformatics projects completed
  • +3 more outcomes

Companies that use Sequentia Biotech

Customer profile

Named customers10 records

Segments6 records

Ideal customer profiles4 records

Sequentia Biotech technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature10 records

Sequentia Biotech partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Oxford Nanopore TechnologiescoreTechnology or IntegrationSequentia Biotech partnered with a large European clinical diagnostics laboratory to implement its Smart Bridge orchestration layer for Oxford Nanopore (ONT) long-read sequencing. The specialized bridge converts raw ONT sequencing output into standardized, clinician-ready reports, creating an automated 'pore to PDF' ecosystem integrated with ONT's sequencing platform.
  • AWS (Amazon Web Services)coreTechnology or IntegrationSequentia Biotech's cloud-based platforms (BatchX, Sequentia Hub, and SaaS products AIR and GAIA) are hosted on cloud infrastructure, with AWS referenced as the hosting provider. The company leverages cloud computing for scalable bioinformatics analysis, data storage, and platform delivery.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Sequentia Biotech competitors and assessment

Company assessment

Broad incumbents

  • QIAGEN: Global life sciences leader providing sample-prep and bioinformatics tools (CLC Genomics Workbench, GeneGlobe) for genomics and clinical diagnostics. Comparable to Sequentia in serving pharma/biotech and clinical labs with integrated bioinformatics, but at vastly larger scale and as part of a broader consumables portfolio.
  • Illumina: Dominant sequencing platform vendor increasingly bundling bioinformatics (DRAGEN, BaseSpace). Comparable as an end-to-end provider for genomics customers, though Illumina's primary moat is sequencing hardware rather than software interpretation.
  • Dotmatics: Scientific R&D informatics platform serving pharma/biotech customers with data management and analysis workflows. Comparable to Sequentia in targeting pharma R&D with integrated data/analysis offerings, though Dotmatics spans broader chemistry and biology informatics.
  • Genedata: Enterprise bioinformatics platform for pharma/biotech R&D with specialized omics and screening analysis modules. Comparable to Sequentia Hub as an enterprise-scale platform for multiomics interpretation in pharma R&D contexts.

Direct peers

  • SOPHiA GENETICS: Clinical genomics AI platform serving hospitals and clinical labs with multiomics interpretation, including metagenomics and rare disease applications. Closely comparable to Sequentia in combining clinical-grade certification, AI-driven interpretation, and SaaS deployment for clinical diagnostics customers.
  • DNAnexus: Cloud-based genomics informatics platform serving pharma/biotech and clinical customers with analysis pipelines and data management. Comparable to Sequentia Hub as a cloud bioinformatics ecosystem, though DNAnexus focuses more on infrastructure and large pharma deployments.
  • Benchling: Cloud platform for biotech R&D including molecular biology and genomics workflows, serving pharma/biotech enterprise customers. Comparable to Sequentia as a SaaS bioinformatics platform for life science R&D, though Benchling's emphasis is broader R&D informatics rather than omics interpretation.
  • Partek: Bioinformatics software provider specializing in genomics and transcriptomics analysis (Partek Flow, Partek Genomics Suite). Comparable to Sequentia's AIR and GINO products for academic and pharma customers seeking user-friendly omics analysis.
  • Qlucore: Visualization and analysis software for omics data including genomics, transcriptomics, and proteomics, serving clinical and research customers. Comparable to Sequentia's AIR/GAIA as a specialized omics interpretation tool with CE-marked clinical variants.
  • Eagle Genomics: Bioinformatics platform applying AI to microbiome and multiomics analysis for enterprise customers in consumer goods, food, and life sciences. Closely comparable to Sequentia's microbiome focus and cross-vertical positioning in food/agriculture/health.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

Sequentia Biotech social profiles

Digital presence

Sequentia Biotech compliance and trust

Trust signal

Compliance4 records

Sequentia Biotech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sequentia Biotech leadership team

Management profile

Number of profiles

Profiles1 record

Sequentia Biotech funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sequentia Biotech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sequentia Biotech

What does Sequentia Biotech do?

Sequentia Biotech develops and sells proprietary bioinformatics software platforms (MICK, GAIA, AIR, GINO, PROKY, SABIO, BatchX, Sequentia Hub) that transform multiomics sequencing data into actionable biological and clinical insights. The company delivers these platforms alongside end-to-end bioinformatics consulting, custom software development, sequencing services, and training programs to pharma, biotech, clinical diagnostic labs, academic institutions, agriculture, and food industry clients across 65+ countries.

Is Sequentia Biotech a public or private company?

Sequentia Biotech is a private company. It is classified as venture growth investor backed and is currently operating.

When was Sequentia Biotech founded?

Sequentia Biotech was founded in 2013. It employs 11 to 50 people.

Where is Sequentia Biotech based?

Sequentia Biotech is headquartered in Barcelona, Spain, in the Europe region.

How does Sequentia Biotech make money?

Six revenue lines are on record. SaaS Software Subscriptions (AIR, GAIA) is the primary driver. The others are bioinformatics Consulting Services, custom Software Development, sequencing Services, training Services and licensed Diagnostic Products (CE-IVD).

Who are Sequentia Biotech's main competitors?

Broad incumbents on record are QIAGEN, Illumina, Dotmatics and Genedata. Direct peers are SOPHiA GENETICS, DNAnexus, Benchling, Partek, Qlucore and Eagle Genomics.

Does Sequentia Biotech have an API?

No public API is recorded for Sequentia Biotech.

What industry is Sequentia Biotech in?

Sequentia Biotech's product category is Bioinformatics Software. Its primary akta.pro industry code is HLAAAFAI, Microbiome Analytics, Sequencing & Bioinformatics Platforms, with a secondary code of HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization. Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Media-outreachSequentia Biotech ottiene la certificazione CE-IVD ai sensi del regolamento IVDR per MICK Clinical™, la nuova soluzione diagnostica per i patogeni gastrointestinaliSequentia Biotech announced CE-IVD certification for MICK Clinical, a NGS-based diagnostic for gastrointestinal pathogens, under the EU IVDR. Clinical testing at Vall d'Hebron Hospital showed 91.7% sensitivity and 99.5% specificity. The certification marks a shift from research-only to clinical use.WebcapitalriesgoSequentia Biotech cierra una ronda de €10M liderada por Seventure. Participa el Fondo EICSequentia Biotech has closed a €10 million Series A funding round led by Seventure Partners, with participation from the European Innovation Council (EIC) Fund. The capital will be used to accelerate the market expansion of its flagship bioinformatics platform, MICK, and enhance its omics analysis technologies. This investment aims to support the company's commercialization strategy in biomedical, agricultural, and food industries.outsourcing-pharma.comMicrobiome startup Sequentia Biotech heralds “new era” in omics with €10 million roundSequentia Biotech raised €10 million in a round led by Seventure Partners and the EIC Fund to accelerate its microbiome-focused healthcare software MICK. The company plans to use the funds to speed market introduction and scale technology development. The global multiomics market is projected to grow from $2.35 billion in 2023 to $6.38 billion by 2030.YahooSequentia secures €10m to advance multiomics softwareSequentia Biotech secured €10m in EU funding to advance its multiomics software, led by Seventure Partners and the EIC Fund. The funds will accelerate market entry of its MICK software for microbiome analysis and personalized medicine. The company also sees potential applications in biomedicine and agri-tech.Business Wire BlogSequentia Biotech Secures €10million Equity Investment from Seventure Partners and the EIC Fund to Boost Bioinformatic Solutions for Clinical, Industrial and Research ApplicationsSequentia Biotech raised a €10 million Series A led by Seventure Partners, co-invested by the EIC Fund. The funding will accelerate its MICK bioinformatics platform and expand omics applications in clinical, industrial, and research settings.SequentiabiotechSequentia Biotech Secures €10million Equity Investment from Seventure Partners and the EIC Fund to Boost Bioinformatic Solutions for Clinical, Industrial and Research ApplicationsSequentia Biotech, a Barcelona-based bioinformatics firm, announced a €10 million Series A round led by French venture capital firm Seventure Partners and co-invested by the European Commission's EIC Fund. The funds will support market introduction and expansion of its MICK microbiome analysis platform and scale-up of its bioinformatics technologies. No valuation was disclosed.